Objective: CanCope is an internet-delivered, cognitive-behavioural intervention adapted from the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders to improve emotion regulation and support the mental health of cancer survivors. Four separate pilot studies evaluated each of CanCope's modules for (1) feasibility and participant satisfaction, and changes in (2) module-specific outcomes, and (3) global measures of emotion dysregulation and anxiety and depressive symptoms, from pre-to-post module delivery. Methods: Eligible cancer survivors self-selected into one two-week online module designed to improve a specific aspect of emotion regulation ([1] understanding emotions, [2] mindfulness of emotions, [3] cognitive reappraisals, [4] challenging emotion-driven behaviours).Results: Across modules, post-intervention surveys were completed by 17-19 participants, (58.1%-90.5% completion rate for participants who received the intervention). Each module was feasible and participants reported high satisfaction.Moderate-to-large pre-to-post effect sizes in mean differences were observed in module-specific target outcomes (p's < 0.05). Emotion dysregulation significantly decreased across modules 1 to 3 (p's < 0.05) with a non-significant decrease for module 4 (p = 0.13). Anxiety symptoms significantly decreased across all modules (p's < 0.05). Depressive symptoms significantly decreased across modules 1 and 3 (p's < 0.05), with non-significant decreases across modules 2 (p = 0.08) and 4 (p = 0.06).Conclusions: Each CanCope module demonstrated promise in targeting emotion regulation skills and supporting the mental health of cancer survivors. Randomised controlled trials are required to test the efficacy of CanCope as an intervention in its entirety.

BACKGROUND Cancer survivors are vulnerable to experiencing symptoms of anxiety and depression and may benefit from accessible interventions focused on improving emotion regulation. CanCope Mind was developed as an internet-delivered intervention adapted from the Unified Protocol (UP) for Transdiagnostic Treatment of Emotional Disorders to improve emotion regulation and support the mental health of cancer survivors. OBJECTIVE This protocol aims to provide an outline of The CanCope Study; a randomized controlled trial comparing the efficacy of an UP-adapted internet-delivered intervention (CanCope Mind) designed for cancer survivors compared to an active control condition – an internet-delivered healthy lifestyle intervention (CanCope Lifestyle). The primary aim is to assess and compare the efficacy of both interventions in improving emotion regulation, anxiety and depressive symptoms, and quality of life. The secondary aims involve assessing the mechanisms of the CanCope Mind intervention. METHODS Cancer survivors will be recruited and randomized to either CanCope Mind or CanCope Lifestyle. Both interventions comprise four online modules and are expected to take participants at least eight weeks to complete. Participants’ mental and physical health will be assessed via self-reported surveys at baseline (T0), between each module (T1, T2, T3), post-intervention (T4), and at three-months follow-up (T5). The study aims to recruit 110 participants who have completed T4. RESULTS The CanCope Study began recruitment in September 2020. As of December 2021, 224 participants have been randomized and 116 have completed the post-intervention survey (T4). Data collection for all timepoints is expected to be finalized by May 2022. CONCLUSIONS This will be one of the first trials to develop and investigate the efficacy of an online intervention for cancer survivors that specifically targets emotion regulation. CLINICALTRIAL ACTRN12620000943943

Background Cancer survivors are vulnerable to experiencing symptoms of anxiety and depression and may benefit from accessible interventions focused on improving emotion regulation. CanCope Mind (CM) was developed as an internet-delivered intervention adapted from the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders to improve emotion regulation and support the mental health of cancer survivors. Objective This protocol aims to provide an outline of the CanCope Study, a trial comparing the efficacy of a Unified Protocol–adapted internet-delivered intervention (CM) designed for cancer survivors compared with an active control condition—an internet-delivered healthy lifestyle intervention, CanCope Lifestyle (CL). The primary aim is to assess and compare the efficacy of both interventions in improving emotion regulation, anxiety and depressive symptoms, and quality of life. The secondary aims involve assessing the mechanisms of the CM intervention. Methods This trial is a 2-arm randomized controlled trial that allocates cancer survivors to either CM or CL. Both interventions comprise 4 web-based modules and are expected to take participants at least 8 weeks to complete. Participants’ mental and physical health will be assessed via self-reported surveys at baseline (T0), between each module (T1, T2, and T3), immediately after the intervention (T4), and at 3-month follow-up (T5). The study aims to recruit 110 participants who have completed T4. Results The CanCope study began recruitment in September 2020. A total of 224 participants have been randomized to the CM (n=110, 49.1%) and CL (n=114, 50.9%) groups. Conclusions This is one of the first trials to develop and investigate the efficacy of a web-based intervention for cancer survivors that specifically targets emotion regulation. Trial Registration Australian Clinical Trials ACTRN12620000943943; https://tinyurl.com/b3z9cjsp International Registered Report Identifier (IRRID) DERR1-10.2196/36658

ObjectivesThis trial assessed the efficacy of an emotion‐focused, modular, Internet‐delivered adaptation of the Unified Protocol (UP) in improving cancer survivors' emotion regulation strategies.DesignA two‐arm randomized controlled trial (1:1) was used to compare the efficacy of two Internet‐based interventions: UP‐adapted CanCope Mind (CM) and lifestyle‐focused active control CanCope Lifestyle (CL).MethodsN = 224 cancer survivors randomized to CM or CL were assessed at baseline, between‐modules, at post‐intervention and 3‐month follow‐up on emotion regulation outcomes targeted by each CM module (Module 1: beliefs about emotions; Module 2: mindfulness; Module 3: cognitive reappraisal skills, catastrophizing, refocus on planning; Module 4: experiential avoidance). Primary analyses were intention‐to‐treat linear regressions using Fisher randomization tests for p‐values and intervals were used to compare groups with standardized mean difference (SMD) effect sizes.ResultsCanCope Mind participants (n = 61 completers) experienced moderate‐to‐large improvements (SMDs from .44–.88) across all outcomes at post‐intervention. CM's effects were larger than CL's (n = 75 completers) immediately post‐intervention and at 3‐month follow‐up for beliefs about emotions, mindfulness, cognitive reappraisals and experiential avoidance (all p's < .05). CM experienced greater improvements in catastrophizing immediately post‐intervention, with a trending effect at follow‐up. However, we could not reject the null hypothesis of identical between‐group effects for refocusing on planning both immediately post‐intervention and at follow‐up. Exploratory analyses revealed inconsistent between‐module effects.ConclusionsIn its entirety, CM is a promising intervention for improving and maintaining cancer survivors' adaptive emotion regulation, especially for mindfulness and experiential avoidance. This may have important clinical implications for promoting cancer survivors’ emotional functioning and general well‐being.